Skip to main content
OpenTrials
Completed

NCT Number: NCT07246928

Ultraspound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 month–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Specialized Pediatric Hospital (Abu EL-Reesh Japanese hospital)

Cairo, Cairo Governorate, 12613, Egypt

About this study

Ultrasound-guided Intralesional Injection of Cystic Hygroma [lymphatic malformation]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pediatric patients of age up to 12 years having cystic hygromas (macrocystic lymphatic malformations), from the vascular anomalies clinic at the pediatric surgery department in Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital). -

Treatment and study plan

Intralesional Injection of Bleomycin

Procedure

Aspiration of Cystic Hygroma Fluid and Intralesional Injection

Primary outcomes

  1. improvement: change in lesion size

    Time frame: one year

    reduction in lesion size

  2. improvement: reduction of lesion size

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Delta University for Science and Technology

Other

Registry information

Official study title

Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Acronym: US: Ultrasound

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 24, 2025
Registry last updated
Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.